Dillon & Associates Inc’s Abbott Laboratories Position
Does Dillon & Associates Inc own Abbott Laboratories (ABT)? Yes — 231.3K shares worth $24M (+3.28% of its 13F portfolio) as of Q1 2026, up from 226.4K shares the prior filed quarter.
Position Value
$24M
Q1 2026
Shares
231.3K
% of Portfolio
+3.28%
Quarters Held
29
currently held
Position History ABT
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 231.3K | $24M | +3.28% |
| Q4 2025 | 226.4K | $28M | +3.65% |
| Q3 2025 | 222.2K | $30M | +3.83% |
| Q2 2025 | 218.7K | $30M | +4.04% |
| Q1 2025 | 214.6K | $29M | +4.24% |
| Q4 2024 | 213.0K | $24M | +3.34% |
| Q3 2024 | 210.3K | $24M | +3.37% |
| Q2 2024 | 206.0K | $21M | +3.11% |
| Q1 2024 | 192.1K | $22M | +3.44% |
| Q4 2023 | 192.4K | $21M | +3.84% |
| Q3 2023 | 196.5K | $19M | +3.67% |
| Q2 2023 | 196.5K | $21M | +3.94% |
| Q1 2023 | 203.0K | $21M | +4.07% |
| Q4 2022 | 205.7K | $23M | +4.89% |
| Q3 2022 | 206.2K | $20M | +4.64% |
| Q2 2022 | 205.8K | $22M | +5.06% |
| Q1 2022 | 205.9K | $24M | +4.61% |
| Q4 2021 | 208.8K | $29M | +5.13% |
| Q3 2021 | 208.7K | $25M | +4.72% |
| Q2 2021 | 208.1K | $24M | +4.73% |
| Q1 2021 | 208.6K | $25M | +5.35% |
| Q4 2020 | 211.2K | $23M | +5.00% |
| Q3 2020 | 214.1K | $23M | +5.63% |
| Q2 2020 | 215.1K | $20M | +5.30% |
| Q1 2020 | 215.6K | $17M | +5.73% |
| Q4 2019 | 211.5K | $18M | +5.15% |
| Q3 2019 | 211.0K | $18M | +5.39% |
| Q2 2019 | 211.0K | $18M | +5.48% |
| Q1 2019 | 208.6K | $17M | +5.42% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Dillon & Associates Inc’s full portfolio or all institutional holders of ABT.